Mingli Li completed her PhD from University of Birmingham, United Kingdom. Her Ph.D. thesis focused on mechanistic analysis of Apoptosis-induced Proliferation (AiP) and non-apoptotic cell death in Drosophila. In April 2017, she joined Prof. Eric Witze’s laboratory at the University of Pennsylvania (UPENN) as a Postdoctoral Researcher. At UPENN, her research focused on understanding the physiological and pathological roles of palmitoylation, a type of protein post-translational modification. In December 2018, she then joined the laboratory of Chun-Wei (David) Chen in the Department of Systems Biology as a Postdoctoral Fellow. She is interested in identifying novel therapeutic targets for leukemia driven by mixed-lineage leukemia gene rearrangement (MLL-r) using CRISPR screening.